"10.1371_journal.pone.0152700","plos one","2016-04-12T00:00:00Z","Kerenaftali Klein; Stefanie Hennig; Sanjoy Ketan Paul","Clinical Trials and Biostatistics Unit, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Australia; School of Pharmacy, University of Queensland, 20 Cornwall Street, Brisbane, Australia","Conceived and designed the experiments: KK SH SP. Analyzed the data: KK SH SP. Wrote the paper: KK SH SP.","KK and SP are employees of QIMR Berghofer Medical Research Institute, and SH is an employee of University of Queensland. QIMR Berghofer Medical Research Institute gratefully acknowledges infrastructure research support from the Australian Governmentâ€™s NCRIS initiative through Therapeutic Innovation Australia. SP has acted as a consultant and speaker for Novartis and Amylin Pharmaceuticals Inc. He has received grants in support as an investigator to conduct investigator initiated clinical studies from Merck, Novo Nordisk, Amylin Pharmaceuticals, Bristol Myers Squibb and Pfizer. KK, SH and SP have no financial interests that may be relevant to the submitted work. Their spouses, partners, or children have no financial relationships that may be relevant to the submitted work. And this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","04","Kerenaftali Klein","KK",3,TRUE,3,NA,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
